HFZS
839725
Hangzhou SDIC Microelectronics Inc.
688130
Henan Liliang Diamond
301071
Sf Diamond Co., Ltd.
300179
Jiangsu Zhengdan Chemical Industry
300641
CN Stock MarketDetailed Quotes
300583 Shandong Sito Bio-technology
- 20.64
- -2.00-8.83%
Market Closed Dec 23 15:00 CST
3.92BMarket Cap-5160.00P/E (TTM)
22.79High20.50Low59.86KlotVolume22.79Open22.64Pre Close127.49MTurnover3.22%Turnover Ratio86.00P/E (Static)189.70MShares31.6352wk High2.02P/B3.84BFloat Cap10.2152wk Low27.17Limit Up186.15MShs Float57.68Historical High18.11Limit Down10.12%Amplitude10.21Historical Low0.45Dividend TTM21.30Avg Price30.41KlotAsk2.18%Div YieldTTM100Lot Size26.65KlotBid
Shandong Sito Bio-technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -17.13%765.03M | -14.62%566.65M | -27.00%244.4M | -2.46%1.28B | -1.04%923.23M | 4.31%663.66M | 31.99%334.79M | 9.10%1.31B | 5.77%932.95M | 2.03%636.24M |
| Operating revenue | -17.13%765.03M | -14.62%566.65M | -27.00%244.4M | -2.46%1.28B | -1.04%923.23M | 4.31%663.66M | 31.99%334.79M | 9.10%1.31B | 5.77%932.95M | 2.03%636.24M |
| Other operating revenue | ---- | 0.46%25.85M | ---- | -22.16%54.57M | ---- | 58.11%25.73M | ---- | 147.16%70.11M | ---- | -3.18%16.27M |
| Total operating cost | -15.13%744.76M | -9.59%553.9M | -23.98%238.47M | -1.82%1.24B | 0.25%877.56M | 2.54%612.62M | 31.16%313.69M | 10.08%1.27B | 4.14%875.33M | -0.90%597.46M |
| Operating cost | -17.76%563.19M | -13.08%420.39M | -28.88%174.82M | -4.34%994.24M | -2.07%684.78M | 1.43%483.64M | 38.35%245.8M | 10.91%1.04B | 3.79%699.25M | -1.16%476.84M |
| Operating tax surcharges | 10.89%10.74M | 15.91%7.71M | -10.31%3.06M | 13.98%13.77M | 11.31%9.68M | 15.12%6.66M | 46.92%3.41M | 49.02%12.08M | 45.34%8.7M | 42.15%5.78M |
| Operating expense | 5.47%12.36M | 12.01%9.18M | 7.77%4.16M | 7.21%15.67M | 34.54%11.72M | 30.35%8.2M | 12.83%3.86M | 6.24%14.61M | -43.22%8.71M | -43.21%6.29M |
| Administration expense | -11.67%92.3M | -2.77%67.48M | -12.62%31.76M | 10.51%128.24M | 6.27%104.49M | 2.31%69.4M | -0.60%36.34M | 2.54%116.04M | 13.95%98.32M | 7.60%67.83M |
| Financial expense | -1.50%24.79M | 4.89%17.63M | 0.84%10.35M | 6.13%37.26M | -11.70%25.17M | -20.14%16.81M | -14.79%10.26M | 18.82%35.11M | 13.71%28.5M | 27.22%21.05M |
| -Interest expense (Financial expense) | -14.13%22.89M | -5.54%16.66M | -8.46%10.37M | 2.09%37.66M | -6.87%26.65M | -14.83%17.64M | -4.74%11.33M | 22.10%36.89M | 16.12%28.62M | 26.83%20.71M |
| -Interest Income (Financial expense) | 10.63%-3.41M | 10.67%-2.24M | -1.46%-1.16M | -27.59%-4.74M | -104.33%-3.82M | -195.65%-2.51M | -191.34%-1.14M | -39.65%-3.71M | 7.14%-1.87M | 5.22%-849.45K |
| Research and development | -0.80%41.39M | 12.84%31.5M | 2.30%14.32M | 9.70%55.08M | 30.98%41.73M | 41.91%27.91M | 96.16%14M | 0.95%50.21M | -6.69%31.86M | -23.48%19.67M |
| Credit Impairment Loss | 172.15%2.33M | 27.96%-2.06M | 77.83%-581.69K | -1,448.86%-5.35M | -66.96%-3.23M | -114.68%-2.86M | -1,333.82%-2.62M | 94.16%-345.59K | 63.21%-1.93M | 78.27%-1.33M |
| Asset Impairment Loss | -1,138.75%-21.71M | -5.97%-6.93M | -361.43%-2.24M | -91.23%-13.17M | 78.60%-1.75M | -335.35%-6.54M | 73.96%-486.49K | 43.21%-6.89M | 33.79%-8.19M | 135.03%2.78M |
| Other net revenue | -51.00%903.15K | 227.22%6.62M | 287.43%2.16M | -162.61%-2.8M | 143.97%1.84M | -210.82%-5.21M | -173.26%-1.15M | -4.92%4.46M | -523.93%-4.19M | 74.93%4.7M |
| Invest income | 215.17%10.87M | 424.07%9.67M | 46.42%1.79M | -54.83%3.61M | 14.63%3.45M | 35.69%1.85M | 126.92%1.22M | 101.43%8M | 0.18%3.01M | -33.90%1.36M |
| -Including: Investment income associates | 11.95%4.37M | 30.38%3.17M | 46.42%1.79M | 3.66%4.27M | 29.78%3.9M | 78.94%2.43M | 126.92%1.22M | 8.30%4.12M | 6.00%3.01M | -28.14%1.36M |
| Asset deal income | -273.05%-285.93K | -273.05%-285.93K | ---- | 228.76%138.87K | 309.77%165.23K | 309.77%165.23K | ---- | -104.25%-107.85K | -210.02%-78.77K | 35.02%-78.77K |
| Other revenue | 202.49%9.7M | 185.41%6.22M | 334.04%3.2M | 214.47%11.97M | 6.93%3.21M | 10.63%2.18M | 5.91%737K | -76.55%3.81M | -80.69%3M | -86.69%1.97M |
| Operating profit | -55.42%21.18M | -57.73%19.37M | -59.48%8.08M | -33.49%32.74M | -11.08%47.51M | 5.41%45.83M | 41.81%19.95M | -12.06%49.22M | 25.60%53.43M | 85.56%43.48M |
| Add:Non operating Income | -99.49%126.77K | -99.54%112.63K | -96.78%100.09 | 14,336.02%25.03M | 293,287.80%24.91M | 422,285.14%24.72M | -40.21%3.11K | -93.58%173.39K | -85.60%8.49K | -89.26%5.85K |
| Less:Non operating expense | -18.82%574.65K | 146.49%550.64K | 30.58%1.39K | 188.46%4.29M | 254.30%707.9K | 443.35%223.39K | -96.60%1.07K | -66.09%1.49M | -42.91%199.8K | -86.30%41.11K |
| Total profit | -71.09%20.73M | -73.08%18.94M | -59.49%8.08M | 11.62%53.48M | 34.69%71.71M | 61.89%70.33M | 42.09%19.95M | -11.75%47.91M | 26.01%53.24M | 87.38%43.44M |
| Less:Income tax cost | 93.15%7.53M | 67.93%5.97M | 80.24%4.37M | -9.42%4.93M | -71.17%3.9M | -70.00%3.55M | 4.57%2.42M | -70.57%5.45M | 12.32%13.53M | 129.54%11.84M |
| Net profit | -80.53%13.2M | -80.58%12.97M | -78.82%3.71M | 14.32%48.55M | 70.75%67.81M | 111.31%66.78M | 49.51%17.53M | 18.67%42.47M | 31.46%39.71M | 75.31%31.6M |
| Net profit from continuing operation | -80.53%13.2M | -80.58%12.97M | -78.82%3.71M | 14.32%48.55M | 70.75%67.81M | 111.31%66.78M | 49.51%17.53M | 18.67%42.47M | 31.46%39.71M | 75.31%31.6M |
| Less:Minority Profit | -122.77%-1.51M | -103.53%-240.41K | -70.48%640.74K | 490.64%2.94M | 517.47%6.65M | 1,025.56%6.81M | 313.08%2.17M | 218.85%498.3K | -15.93%-1.59M | 24.64%-736.01K |
| Net profit of parent company owners | -75.94%14.72M | -77.97%13.21M | -80.00%3.07M | 8.67%45.6M | 48.06%61.16M | 85.43%59.97M | 20.53%15.36M | 15.91%41.97M | 30.79%41.31M | 70.17%32.34M |
| Earning per share | ||||||||||
| Basic earning per share | -84.00%0.08 | -87.27%0.07 | -77.78%0.02 | 4.17%0.25 | 108.33%0.5 | 83.33%0.55 | -25.00%0.09 | -29.41%0.24 | -20.00%0.24 | 66.67%0.3 |
| Diluted earning per share | -84.00%0.08 | -87.27%0.07 | -77.78%0.02 | 4.17%0.25 | 108.33%0.5 | 83.33%0.55 | -25.00%0.09 | -29.41%0.24 | -20.00%0.24 | 66.67%0.3 |
| Other composite income | 131.96%1.1M | 133.01%1.1M | 164.64%986.43K | -107.77%-4.12M | -403.13%-3.43M | -173.05%-3.32M | 67.26%-1.53M | -140.97%-1.98M | -128.97%-682.44K | -150.56%-1.22M |
| Other composite income of parent company owners | 135.34%1.1M | 136.50%1.1M | 158.48%892.03K | -118.73%-3.73M | -408.24%-3.1M | -175.83%-3.01M | 67.03%-1.53M | -139.32%-1.7M | -129.20%-610.92K | -150.95%-1.09M |
| Other composite income of minority owners | ---- | ---- | 13,748.94%94.4K | -41.02%-394.53K | -359.44%-328.59K | -149.34%-318.17K | 97.98%-691.64 | -155.13%-279.77K | -127.18%-71.52K | -147.43%-127.6K |
| Total composite income | -77.79%14.3M | -77.83%14.07M | -70.64%4.7M | 9.74%44.42M | 64.94%64.38M | 108.83%63.46M | 126.60%16M | -0.36%40.48M | 19.86%39.03M | 48.69%30.39M |
| Total composite income of parent company owners | -72.76%15.81M | -74.88%14.31M | -71.35%3.96M | 4.01%41.88M | 42.65%58.05M | 82.28%56.96M | 70.46%13.83M | -0.68%40.26M | 20.85%40.69M | 47.80%31.25M |
| Total composite income of minority owners | -123.95%-1.51M | -103.70%-240.41K | -66.11%735.15K | 1,066.27%2.55M | 479.80%6.32M | 851.96%6.49M | 306.10%2.17M | 147.69%218.53K | -49.81%-1.67M | -22.05%-863.61K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.